NA Heerema

1.9k total citations
21 papers, 998 citations indexed

About

NA Heerema is a scholar working on Public Health, Environmental and Occupational Health, Genetics and Oncology. According to data from OpenAlex, NA Heerema has authored 21 papers receiving a total of 998 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Public Health, Environmental and Occupational Health, 9 papers in Genetics and 6 papers in Oncology. Recurrent topics in NA Heerema's work include Acute Lymphoblastic Leukemia research (12 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Lymphoma Diagnosis and Treatment (5 papers). NA Heerema is often cited by papers focused on Acute Lymphoblastic Leukemia research (12 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Lymphoma Diagnosis and Treatment (5 papers). NA Heerema collaborates with scholars based in United States and Netherlands. NA Heerema's co-authors include G. Denman Hammond, Fatih M. Uckun, ME Trigg, W. Archie Bleyer, KJ Gajl-Peczalska, PH Sorensen, S J Korsmeyer, JH Kersey, GH Reaman and CS Chen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Leukemia.

In The Last Decade

NA Heerema

21 papers receiving 965 citations

Peers

Countries citing papers authored by NA Heerema

Since Specialization

Citations

This map shows the geographic impact of NA Heerema's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by NA Heerema with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites NA Heerema more than expected).

Fields of papers citing papers by NA Heerema

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by NA Heerema. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by NA Heerema. The network helps show where NA Heerema may publish in the future.

Co-authorship network of co-authors of NA Heerema

This figure shows the co-authorship network connecting the top 25 collaborators of NA Heerema. A scholar is included among the top collaborators of NA Heerema based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with NA Heerema. NA Heerema is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Final results of CA180-372/COG AALL1122 phase 2 trial of dasatinib and chemotherapy in pediatric patients with newly-diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (PH plus ALL) 2020 ·Stephen P. Hunger, Vaskar Saha, Meenakshi Devidas, M. Valsecchi, Julie M. Gastier‐Foster, Giovanni Cazzaniga, Shalini C. Reshmi, M Borowitz, Anthony V. Moorman, NA Heerema, Andrew J. Carroll, René Swanink, Peter Martin, Mignon L. Loh, Elizabeth A. Raetz, Konrad Schultz, William B. Slayton, Martin Schrappe, L. B. Silverman, Andrea Biondi	3
2	Activity and tolerability of the Bruton's tyrosine kinase (Btk) inhibitor PCI-32765 in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): Interim results of a phase Ib/II study. 2011 ·Journal of Clinical Oncology ·John C. Byrd, (unknown), Jan A. Burger, Steven Coutré, Jeffrey P. Sharman, Richard R. Furman, Ian W. Flinn, Barbara Grant, Donald Richards, (unknown), NA Heerema, (unknown), Raquel Izumi, Ahmed Hamdy, Susan O’Brien	25
3	Phase I study of the CDK inhibitor dinaciclib (SCH 727965) in patients (pts) with relapsed/refractory CLL. 2011 ·Journal of Clinical Oncology ·Joseph M. Flynn, Justin A. Jones, Leslie A. Andritsos, Kristie A. Blum, (unknown), (unknown), Elizabeth Wiley, NA Heerema, Jennifer Poon, Karen Small, Ying-Ming Jou, (unknown), Paul Statkevich, M. R. Grever, Rajat Bannerji, John C. Byrd	10
4	Comparison of high-dose methotrexate (HD-MTX) with Capizzi methotrexate plus asparaginase (C-MTX/ASNase) in children and young adults with high-risk acute lymphoblastic leukemia (HR-ALL): A report from the Children’s Oncology Group Study AALL0232. 2011 ·Journal of Clinical Oncology ·Eric Larsen, Wanda L. Salzer, Meenakshi Devidas, James B. Nachman, Elizabeth A. Raetz, Mignon L. Loh, NA Heerema, Andrew J. Carroll, Julie M. Gastier‐Foster, Michael J. Borowitz, Brent L. Wood, Cheryl L. Willman, Naomi Winick, Stephen P. Hunger, William L. Carroll	29
5	9p rearrangements in ALL 2011 ·Atlas of Genetics and Cytogenetics in Oncology and Haematology ·NA Heerema	2
6	Dexamethasone (DEX) versus prednisone (PRED) during induction for children with high-risk acute lymphoblastic leukemia (HR-ALL): A report from the Children’s Oncology Group Study AALL0232. 2011 ·Journal of Clinical Oncology ·Naomi Winick, Wanda L. Salzer, Meenakshi Devidas, James B. Nachman, Elizabeth A. Raetz, Mignon L. Loh, NA Heerema, Andrew J. Carroll, Julie M. Gastier‐Foster, Michael J. Borowitz, Brent L. Wood, Cheryl L. Willman, Stephen P. Hunger, William L. Carroll, Eric Larsen	13
7	Cytogenetic and early-response characteristics of adolescents and young adults with acute lymphoblastic leukemia (ALL): A Children's Oncology Group (COG) study. 2010 ·Journal of Clinical Oncology ·Elizabeth A. Raetz, Meenakshi Devidas, Andrew J. Carroll, NA Heerema, Michael J. Borowitz, Brent L. Wood, Julie M. Gastier‐Foster, Cheryl L. Willman, Mignon L. Loh, Eric Larsen	7
8	A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma 2009 ·Leukemia ·Jennifer A. Woyach, Thomas S. Lin, Margaret S. Lucas, NA Heerema, Mollie E. Moran, Carolyn Cheney, David Lucas, Lai Wei, Michael A. Caligiuri, John C. Byrd	25
9	Lumiliximab in combination with FCR for the treatment of relapsed chronic lymphocytic leukemia (CLL): results from a phase I/II multicenter study 2008 ·Journal of Clinical Oncology ·John C. Byrd, (unknown), Ian W. Flinn, (unknown), TJ Kipps, NA Heerema, T. S. Lin, Hua Mu, Shabnam Tangri, (unknown)	6
10	Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995 2000 ·Leukemia ·(unknown), ME Trigg, NA Heerema, (unknown), (unknown), G. Denman Hammond, W. Archie Bleyer	240
11	Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11) – a report of the Children’s Cancer Group 1999 ·Leukemia ·NA Heerema, (unknown), (unknown), (unknown), (unknown), M Trigg, (unknown)	73
12	Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group. 1998 ·Journal of Clinical Oncology ·Fatih M. Uckun, Martha G. Sensel, H N Sather, P S Gaynon, DC Arthur, Beverly J. Lange, Peter G. Steinherz, Peter Kraft, Raymond J. Hutchinson, James B. Nachman, Gregory H. Reaman, NA Heerema	100
13	Dicentric (9;12) in acute lymphocytic leukemia and other hematological malignancies: report from a dic(9;12) study group. 1995 ·PubMed ·H. Behrendt, C Charrin, Barbara Gibbons, Christine J. Harrison, (unknown), NA Heerema, (unknown), J. L. Huret, Jean Luc Laı̈, F. Lampert	26
14	Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome 1993 ·Blood ·CS Chen, PH Sorensen, (unknown), GH Reaman, S J Korsmeyer, NA Heerema, G. Denman Hammond, JH Kersey	191
15	Pediatric leukemia/lymphoma with t(8;14)(q24;q11). 1992 ·PubMed ·Beverly J. Lange, Susana C. Raimondi, NA Heerema, Peter C. Nowell̀, Jun Minowada, (unknown), Edward B. Arenson, Rosemary O’Connor, D Santoli	25
16	Immunophenotype-karyotype associations in human acute lymphoblastic leukemia 1989 ·Blood ·Fatih M. Uckun, KJ Gajl-Peczalska, (unknown), NA Heerema	59
17	Immunophenotype-karyotype associations in human acute lymphoblastic leukemia 1989 ·Blood ·Fatih M. Uckun, KJ Gajl-Peczalska, (unknown), NA Heerema	63
18	B-cell growth factor receptor expression and B-cell growth factor response of leukemic B cell precursors and B lineage lymphoid progenitor cells 1987 ·Blood ·Fatih M. Uckun, (unknown), NA Heerema, CW Song, SR Mehta, K Gajl-Peczalska, (unknown), J L Ambrus	65
19	B-cell growth factor receptor expression and B-cell growth factor response of leukemic B cell precursors and B lineage lymphoid progenitor cells 1987 ·Blood ·Fatih M. Uckun, (unknown), NA Heerema, CW Song, SR Mehta, K Gajl-Peczalska, (unknown), (unknown)	7
20	Localization of the human salivary protein complex (SPC) to chromosome band 12p13.2 1985 ·Cytogenetic and Genome Research ·(unknown), NA Heerema, Catherine G. Palmer, Karen M. Lyons, Robert C. Karn	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact